Table 4.
Biological Function | P Value | Genes, n |
---|---|---|
Males | ||
Diseases and disorders | ||
Cancer | 1.04 × 10−14 to 1.69 × 10−88 | 4,093 |
Organismal injury and abnormalities | 1.04 × 10−14 to 1.69 × 10−88 | 4,206 |
Endocrine system disorders | 1.03 × 10−27 to 2.92 × 10−70 | 3,316 |
Gastrointestinal disease | 6.12 × 10−15 to 9.14 × 10−57 | 3,682 |
Inflammatory response | 9.02 × 10−15 to 7.51 × 10−54 | 1,364 |
Molecular and cellular functions | ||
Cell death and survival | 7.61 × 10−15 to 2.49 × 10−72 | 1,622 |
Cellular movement | 7.21 × 10−15 to 6.10 × 10−68 | 1,216 |
Cellular compromise | 5.16 × 10−19 to 7.51 × 10−54 | 354 |
Cell-to-cell signaling and interaction | 1.07 × 10−14 to 6.98 × 10−41 | 953 |
Lipid metabolism | 1.10 × 10−14 to 1.40 × 10−39 | 797 |
Top toxicology list | Overlap (ratio) | |
NRF2-mediated oxidative stress response | 2.83 × 10−15 | 42.1% (101/240) |
Liver necrosis/cell death | 6.98 × 10−15 | 38.5% (124/322) |
Renal necrosis/cell death | 1.40 × 10−14 | 33.3% (191/573) |
Hepatic fibrosis | 1.41 × 10−13 | 51.4% (57/111) |
Xenobiotic metabolism signaling | 1.19 × 10−11 | 35.2% (123/349) |
Females | ||
Diseases and disorders | ||
Cancer | 8.17 × 10−15 to 2.35 × 10−78 | 3,434 |
Organismal injury and abnormalities | 1.86 × 10−14 to 2.35 × 10−78 | 3,528 |
Endocrine system disorders | 1.94 × 10−36 to 3.14 × 10−64 | 2,815 |
Inflammatory response | 1.29 × 10−14 to 7.07 × 10−56 | 1,187 |
Gastrointestinal disease | 1.09 × 10−14 to 3.97 × 10−51 | 3,122 |
Molecular and cellular functions | ||
Cell death and survival | 1.35 × 10−14 to 7.31 × 10−58 | 1,375 |
Cellular movement | 1.32 × 10−14 to 2.23 × 10−55 | 999 |
Cellular compromise | 1.35 × 10−14 to 4.09 × 10−55 | 374 |
Cellular function and maintenance | 2.32 × 10−15 to 1.81 × 10−50 | 1,237 |
Cell-to-cell signaling and interaction | 1.75 × 10−14 to 1.79 × 10−41 | 707 |
Top toxicology list | Overlap (ratio) | |
Hepatic fibrosis | 2.00 × 10−16 | 50.5% (56/111) |
Renal necrosis/cell death | 5.35 × 10−13 | 28.4% (163/573) |
Liver necrosis/cell death | 1.11 × 10−12 | 32.6% (105/322) |
Increases liver steatosis | 3.83 × 10−12 | 45.0% (49/109) |
Data represent the number of genes up- or downregulated in American lifestyle-induced obesity syndrome (ALIOS) diet-fed mice at 52 wk. Biological functions, molecular functions, and top toxicology lists were assigned using findings extracted from literature and stored in Ingenuity Pathway Analysis (IPA). P values were determined by IPA software using Fisher exact test and determine the probability that the pathway or function assigned is explained by chance alone. The percentage overlap and ratio were calculated from the number of observed genes compared with the number of known genes for that category in the Ingenuity Knowledge Base. NRF2, nuclear factor erythroid 2-related factor 2.